Table 2 Medication according to BMI groups in the 18-year follow-up visit
Medication |  < 18.5 N = 21 | 18.5-24.9 N = 237 | 25–29.9 N = 59 | ≥ 30.0 N = 38 | P value* |
|---|---|---|---|---|---|
NSAIDs | 1(5) | 39(16) | 10(17) | 9(24) | 0.15 |
sDMARD or bDMARD | 7(33) | 71(30) | 15(25) | 13(34) | 0.99 |
sDMARD | 5(24) | 48(20) | 9(15) | 8(21) | 0.66 |
bDMARD | 5(24) | 50(21) | 11(19) | 8(21) | 0.76 |
prednisolone | 1(5) | 7(3) | 2(3) | 0(0) | 0.47 |
methotrexate | 2(10) | 34(14) | 5(8) | 6(16) | 0.99 |
azathioprine | 1(5) | 2(1) | 0(0) | 1(3) | 0.99 |
hydroxychloroquine | 0(0) | 6(3) | 1(2) | 0(0) | 0.99 |
leflunomide | 1(5) | 3(1) | 0(0) | 0(0) | 0.16 |
sulfasalazine | 0(0) | 8(3) | 4(7) | 1(3) | 0.60 |
cyclosporine | 1(5) | 1(0) | 1(2) | 0(0) | 0.87 |